BridgeMD
New treatment option for Parent-Child Relationships
Official title Integrating Evidence-based Approaches to Prevent Child Maltreatment in Kyrgyzstan
ClinicalTrials.gov ID: NCT07712822
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn if a family-based prevention program works to prevent child maltreatment risk and other adverse childhood experiences (ACEs) among families in Kyrgyzstan. It will also learn about the safety, feasibility, and acceptability of the program.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 74. Healthy volunteers may be eligible.
You may be able to join if
- Two adult caregivers (≥18 years old) who identify as co-parents or primary caregivers of a target child
- Target child aged 6-9 years enrolled in one of the participating schools in Bishkek, Kyrgyzstan
- Both caregivers identify each other as family members responsible for the care of the child (e.g., parents, grandparents, or other adult caregivers)
- Both caregivers report feeling safe participating together in a family-based program
- Both caregivers are fluent in either Russian or Kyrgyz
You likely can't join if
- Report of severe physical or sexual intimate partner violence between caregivers within the past 12 months, as assessed during screening
- Either caregiver is unable to provide informed consent
- Either caregiver has a cognitive impairment or a severe mental health condition that would preclude participation in group sessions
- Family plans to relocate outside the study area during the intervention period
- Child has a severe developmental or medical condition that would prevent participation in assessments
- Inability to communicate in Russian or Kyrgyz.
See the full eligibility criteria
- Two adult caregivers (≥18 years old) who identify as co-parents or primary caregivers of a target child
- Target child aged 6-9 years enrolled in one of the participating schools in Bishkek, Kyrgyzstan
- Both caregivers identify each other as family members responsible for the care of the child (e.g., parents, grandparents, or other adult caregivers)
- Both caregivers report feeling safe participating together in a family-based program
- Both caregivers are fluent in either Russian or Kyrgyz
- Both caregivers are able and willing to provide informed consent
- Child is able to provide assent and participate in age-appropriate assessments.
- Family is willing to participate in study procedures, including random assignment and completion of assessments at baseline, post-intervention (16 weeks), and end-of-school-year follow-up.
- Report of severe physical or sexual intimate partner violence between caregivers within the past 12 months, as assessed during screening
- Either caregiver is unable to provide informed consent
- Either caregiver has a cognitive impairment or a severe mental health condition that would preclude participation in group sessions
- Family plans to relocate outside the study area during the intervention period
- Child has a severe developmental or medical condition that would prevent participation in assessments
- Inability to communicate in Russian or Kyrgyz.
The study team makes the final eligibility decision.
Where it's taking place
- Bishkek, Kyrgyzstan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 74 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bishkek, Kyrgyzstan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.